Liver Diseases, Alcoholic
Recent clinical, regulatory, research and industry developments relating to this disease.
Global burden of liver disease: 2023 update.
Endoplasmic reticulum stress in liver diseases.
The gut-liver axis in liver disease: Pathophysiological basis for therapy.
The gut microbiota and host health: a new clinical frontier.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 1 clinical trial expected to report results, the earliest in Q3 2027.
Clinical MilestonesViewHide
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes8
- Liver Diseases, Alcoholic3
- Endoplasmic Reticulum Stress2
- Gastrointestinal Microbiome2
- Non-alcoholic Fatty Liver Disease2
- Alcoholism1
- Carcinoma, Hepatocellular1
- Coumarins1
- Health Status1
Leading journals6
- Hepatology (Baltimore, Md.)2
- Journal of hepatology2
- Alcohol research : current reviews1
- Gut1
- Gut microbes1
- International journal of molecular sciences1
Leading researchers8
- Abadía-Molina F1
- Adams DH1
- Ajoolabady A1
- Albillos A1
- Álvarez-Mercado AI1
- Arab JP1
- Asrani SK1
- Bajaj JS1
Affiliations (unnormalised)6
- Alcohol Research Center1
- Baylor University Medical Center1
- Centre de Recherche des Cordeliers1
- Centre for Liver Research1
- Children's Hospital of Eastern Ontario Research Institute1
- College of Food Science and Engineering1
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Disease profile
A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.
Alcoholic liver disease is a group of liver disorders associated with alcoholism. It usually includes alcoholic fatty liver, alcoholic hepatitis, and alcoholic cirrhosis as related subentities.
The grounding supports chronic alcohol use as the central cause of alcoholic liver disease. It is described as liver damage associated with alcoholism and alcohol consumption, with alcohol being a major cause of liver injury and death.
The literature links alcoholic liver disease to disruption of the gut-liver axis, including alcohol-related changes in the gut microbiota, increased gut permeability, and translocation of bacterial products such as lipopolysaccharide to the liver. Endoplasmic reticulum stress is also implicated, with misfolded protein accumulation activating the unfolded protein response; if sustained, this can contribute to hepatocyte injury and disease progression.
Alcoholism and chronic alcohol use are the main risk factors supported by the grounding. The literature also notes that alcohol alters the gut microbiota and promotes bacterial overgrowth, which is associated with progression of alcohol-associated liver disease.
The grounding supports treatment approaches at the level of alcohol use disorder pharmacotherapy and microbiota-directed strategies. It also mentions fecal microbiota transplantation as a therapeutic strategy under investigation for alcohol-associated alterations, but does not provide a standard regimen for liver disease itself.
AI-generated summary grounded in MeSH and 6 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.
Reference
Authoritative identity, definition & identifiers.
Liver diseases associated with ALCOHOLISM. It usually refers to the coexistence of two or more subentities, i.e., ALCOHOLIC FATTY LIVER; ALCOHOLIC HEPATITIS; and ALCOHOLIC CIRRHOSIS.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.